PURPOSE: Microaneurysms (MAs) are considered a hallmark of retinal vascular disease, yet what little is known about them is mostly based upon histology, not clinical observation. Here, we use the recently developed adaptive optics scanning light ophthalmoscope (AOSLO) fluorescein angiography (FA) to image human MAs in vivo and to expand on previously described MA morphologic classification schemes. METHODS: Patients with vascular retinopathies (diabetic, hypertensive, and branch and central retinal vein occlusion) were imaged with reflectance AOSLO and AOSLO FA. Ninety-three MAs, from 14 eyes, were imaged and classified according to appearance into six morphologic groups: focal bulge, saccular, fusiform, mixed, pedunculated, and irregular. The MA perimeter, area, and feret maximum and minimum were correlated to morphology and retinal pathology. Select MAs were imaged longitudinally in two eyes. RESULTS: Adaptive optics scanning light ophthalmoscope fluorescein angiography imaging revealed microscopic features of MAs not appreciated on conventional images. Saccular MAs were most prevalent (47%). No association was found between the type of retinal pathology and MA morphology (P = 0.44). Pedunculated and irregular MAs were among the largest MAs with average areas of 4188 and 4116 μm(2), respectively. Focal hypofluorescent regions were noted in 30% of MAs and were more likely to be associated with larger MAs (3086 vs. 1448 μm(2), P = 0.0001). CONCLUSIONS: Retinal MAs can be classified in vivo into six different morphologic types, according to the geometry of their two-dimensional (2D) en face view. Adaptive optics scanning light ophthalmoscope fluorescein angiography imaging of MAs offers the possibility of studying microvascular change on a histologic scale, which may help our understanding of disease progression and treatment response.
PURPOSE:Microaneurysms (MAs) are considered a hallmark of retinal vascular disease, yet what little is known about them is mostly based upon histology, not clinical observation. Here, we use the recently developed adaptive optics scanning light ophthalmoscope (AOSLO) fluorescein angiography (FA) to image human MAs in vivo and to expand on previously described MA morphologic classification schemes. METHODS:Patients with vascular retinopathies (diabetic, hypertensive, and branch and central retinal vein occlusion) were imaged with reflectance AOSLO and AOSLO FA. Ninety-three MAs, from 14 eyes, were imaged and classified according to appearance into six morphologic groups: focal bulge, saccular, fusiform, mixed, pedunculated, and irregular. The MA perimeter, area, and feret maximum and minimum were correlated to morphology and retinal pathology. Select MAs were imaged longitudinally in two eyes. RESULTS: Adaptive optics scanning light ophthalmoscope fluorescein angiography imaging revealed microscopic features of MAs not appreciated on conventional images. Saccular MAs were most prevalent (47%). No association was found between the type of retinal pathology and MA morphology (P = 0.44). Pedunculated and irregular MAs were among the largest MAs with average areas of 4188 and 4116 μm(2), respectively. Focal hypofluorescent regions were noted in 30% of MAs and were more likely to be associated with larger MAs (3086 vs. 1448 μm(2), P = 0.0001). CONCLUSIONS: Retinal MAs can be classified in vivo into six different morphologic types, according to the geometry of their two-dimensional (2D) en face view. Adaptive optics scanning light ophthalmoscope fluorescein angiography imaging of MAs offers the possibility of studying microvascular change on a histologic scale, which may help our understanding of disease progression and treatment response.
Authors: Haiyan Wang; Jay Chhablani; William R Freeman; Candy K Chan; Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng Journal: Am J Ophthalmol Date: 2012-02-01 Impact factor: 5.258
Authors: Flavio E Hirai; Scot E Moss; Michael D Knudtson; Barbara E K Klein; Ronald Klein Journal: Am J Epidemiol Date: 2007-06-24 Impact factor: 4.897
Authors: Tien Yin Wong; Ronald Klein; A Richey Sharrett; F Javier Nieto; Lori L Boland; David J Couper; Thomas H Mosley; Barbara E K Klein; Larry D Hubbard; Moyses Szklo Journal: Stroke Date: 2002-06 Impact factor: 7.914
Authors: Boy Braaf; Kari V Vienola; Christy K Sheehy; Qiang Yang; Koenraad A Vermeer; Pavan Tiruveedhula; David W Arathorn; Austin Roorda; Johannes F de Boer Journal: Biomed Opt Express Date: 2012-12-11 Impact factor: 3.732
Authors: Toco Y P Chui; Michael Dubow; Alexander Pinhas; Nishit Shah; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Alfredo Dubra; Richard B Rosen Journal: Biomed Opt Express Date: 2014-03-13 Impact factor: 3.732
Authors: Alexander Pinhas; Moataz Razeen; Michael Dubow; Alexander Gan; Toco Y Chui; Nishit Shah; Mitul Mehta; Ronald C Gentile; Rishard Weitz; Joseph B Walsh; Yusufu N Sulai; Joseph Carroll; Alfredo Dubra; Richard B Rosen Journal: Invest Ophthalmol Vis Sci Date: 2014-11-20 Impact factor: 4.799
Authors: Yang Lu; Miguel O Bernabeu; Jan Lammer; Charles C Cai; Martin L Jones; Claudio A Franco; Lloyd Paul Aiello; Jennifer K Sun Journal: Biomed Opt Express Date: 2016-11-04 Impact factor: 3.732
Authors: Toco Yuen Ping Chui; Alexander Pinhas; Alexander Gan; Moataz Razeen; Nishit Shah; Eric Cheang; Chun L Liu; Alfredo Dubra; Richard B Rosen Journal: Ophthalmic Physiol Opt Date: 2016-01-24 Impact factor: 3.117
Authors: Drew Scoles; Brian P Higgins; Robert F Cooper; Adam M Dubis; Phyllis Summerfelt; David V Weinberg; Judy E Kim; Kimberly E Stepien; Joseph Carroll; Alfredo Dubra Journal: Invest Ophthalmol Vis Sci Date: 2014-06-03 Impact factor: 4.799